title: Local and systemic innate immune response to secondary human peritonitis.
abstract: BACKGROUND
  Our aim was to describe inflammatory cytokines response in the peritoneum and plasma of patients with peritonitis. We also tested the hypothesis that scenarios associated with worse outcome would result in different cytokine release patterns. Therefore, we compared cytokine responses according to the occurrence of septic shock, mortality, type of peritonitis and peritoneal microbiology.
  
  
  METHODS
  Peritoneal and plasma cytokines (interleukin (IL) 1, tumor necrosis factor α (TNFα), IL-6, IL-10, and interferon γ (IFNγ)) were measured in 66 patients with secondary peritonitis.
  
  
  RESULTS
  The concentration ratio between peritoneal fluid and plasma cytokines varied from 5 (2 to 21) (IFNγ) to 1310 (145 to 3888) (IL-1). There was no correlation between plasma and peritoneal fluid concentration of any cytokine. In the plasma, TNFα, IL-6, IFNγ and IL-10 were higher in patients with shock versus no shock and in nonsurvivors versus survivors (P ≤0.03). There was no differential plasma release for any cytokine between community-acquired and postoperative peritonitis. The presence of anaerobes or Enterococcus species in peritoneal fluid was associated with higher plasma TNFα: 50 (37 to 106) versus 38 (29 to 66) and 45 (36 to 87) versus 39 (27 to 67) pg/ml, respectively (P = 0.02). In the peritoneal compartment, occurrence of shock did not result in any difference in peritoneal cytokines. Peritoneal IL-10 was higher in patients who survived (1505 (450 to 3130) versus 102 (9 to 710) pg/ml; P = 0.04). The presence of anaerobes and Enterococcus species was associated with higher peritoneal IFNγ: 2 (1 to 6) versus 10 (5 to 28) and 7 (2 to 39) versus 2 (1 to 6), P = 0.01 and 0.05, respectively).
  
  
  CONCLUSIONS
  Peritonitis triggers an acute systemic and peritoneal innate immune response with a simultaneous release of pro and anti-inflammatory cytokines. Higher levels of all cytokines were observed in the plasma of patients with the most severe conditions (shock, non-survivors), but this difference was not reflected in their peritoneal fluid. There was always a large gradient in cytokine concentration between peritoneal and plasma compartments highlighting the importance of compartmentalization of innate immune response in peritonitis.
authors.forename: Florence
authors.initials: F
authors.lastname: Riché
authors.forename: Etienne
authors.initials: E
authors.lastname: Gayat
authors.forename: Corinne
authors.initials: C
authors.lastname: Collet
authors.forename: Joaquim
authors.initials: J
authors.lastname: Matéo
authors.forename: Marie-Josèphe
authors.initials: MJ
authors.lastname: Laisné
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Launay
authors.forename: Patrice
authors.initials: P
authors.lastname: Valleur
authors.forename: Didier
authors.initials: D
authors.lastname: Payen
authors.forename: Bernard P
authors.initials: BP
authors.lastname: Cholley
mesh_terms: D000368:Aged; D015331:Cohort Studies; D016207:Cytokines / Q000097:blood / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000097:blood / Q000175:diagnosis* / Q000276:immunology*; D011446:Prospective Studies
chemical_list: D016207:Cytokines
references.citation: J Immunol. 1995 Dec 1;155(11):5397-401
references.pmid: 7594556
references.citation: Crit Care. 2010;14(3):R96
references.pmid: 20504311
references.citation: Clin Infect Dis. 2001 Nov 1;33(9):1513-9
references.pmid: 11568851
references.citation: Infect Immun. 1998 May;66(5):2300-9
references.pmid: 9573121
references.citation: J Infect Dis. 1994 Apr;169(4):821-30
references.pmid: 8133097
references.citation: Shock. 2005 Oct;24(4):396-401
references.pmid: 16205327
references.citation: J Immunol. 2006 Aug 1;177(3):1967-74
references.pmid: 16849510
references.citation: Crit Care Med. 2000 Feb;28(2):433-7
references.pmid: 10708179
references.citation: Eur J Surg. 1993 Sep;159(9):475-9
references.pmid: 8274555
references.citation: Surgery. 1996 Jun;119(6):694-700
references.pmid: 8650611
references.citation: Infect Immun. 1976 Jan;13(1):22-6
references.pmid: 814099
references.citation: Nat Med. 1997 Jun;3(6):678-81
references.pmid: 9176497
references.citation: Cytokine. 2012 Mar;57(3):332-6
references.pmid: 22197776
references.citation: Immunobiology. 2012 Jun;217(6):616-21
references.pmid: 22204813
references.citation: Arch Surg. 1995 Dec;130(12):1314-9; discussion 1319-20
references.pmid: 7492280
references.citation: Crit Care Med. 2008 Apr;36(4):1125-8
references.pmid: 18379237
references.citation: Am J Surg. 2001 Nov;182(5):491-7
references.pmid: 11754857
references.citation: Infect Immun. 1997 Jan;65(1):144-9
references.pmid: 8975904
references.citation: Crit Care. 2009;13(3):R99
references.pmid: 19552799
references.citation: Crit Care. 2011;15(5):R252
references.pmid: 22027436
references.citation: J Immunol. 1993 Jul 15;151(2):916-21
references.pmid: 8335919
references.citation: Infect Immun. 1974 Dec;10(6):1256-9
references.pmid: 4611923
references.citation: Shock. 2004 Dec;22(6):521-6
references.pmid: 15545822
references.citation: Am J Respir Crit Care Med. 2001 Feb;163(2):316-21
references.pmid: 11179099
references.citation: Br J Surg. 1994 Sep;81(9):1306-8
references.pmid: 7953393
references.citation: Crit Care Med. 2006 Mar;34(3):646-52
references.pmid: 16505648
references.citation: Ann Surg. 1992 Apr;215(4):356-62
references.pmid: 1558416
references.citation: Crit Care Med. 2010 Jan;38(1):223-41
references.pmid: 19770740
references.citation: Crit Care Med. 2009 Oct;37(10):2746-52
references.pmid: 19707128
references.citation: Intensive Care Med. 2002 May;28(5):594-8
references.pmid: 12029408
references.citation: Crit Care Med. 2008 Apr;36(4):1369-70
references.pmid: 18379273
references.citation: Shock. 2001 Feb;15(2):95-100
references.pmid: 11220648
references.citation: Scand J Infect Dis. 1992;24(3):361-8
references.pmid: 1509242